Abstract
The B-RafV600E mutant, found in 65% of human melanomas, drives constitutive activation of the extracellular signal-regulated kinase (ERK) pathway and is implicated in tumorigenesis. Recently, we showed that B-Raf is important for spindle formation and the mitotic spindle checkpoint arrest. In this study, we demonstrate that B-RafV600E signaling deregulates the spindle checkpoint as a consequence of stabilizing monopolar spindle 1 (Mps1) levels in human melanoma cells. Upon introducing the B-RafV600E mutant into wild-type B-Raf melanoma cells, Mps1 protein and activity increased 3- and 10-fold, respectively. In addition, Mps1 became hyperphosphorylated, which correlated with stabilization of Mps1 protein levels. In contrast, reduction of B-Raf by RNAi or inactivation of ERK by the MEK inhibitor U0126 resulted in a precipitous decline in Mps1 levels. Together, these results suggest that B-Raf signaling through ERK regulates the stability of Mps1. Finally, B-RafV600E expression induces a mitotic delay due to promoting robust activation of the mitotic spindle checkpoint. These effects were dependent on the induction of Mps1 levels by oncogenic B-RafV600E as shown by depleting Mps1 with short interfering RNA. Collectively, our findings implicate a new mechanism through which B-RafV600E exerts its oncogenic effects in melanoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
Abbreviations
- APC:
-
anaphase-promoting complex
- CHX:
-
cycloheximide
- ERK:
-
extracellular signal-regulated kinase
- IP:
-
immunoprecipitation
- Mps1:
-
monopolar spindle 1
- SCR:
-
scrambled siRNA
- siRNA:
-
short interfering RNA
- WB:
-
western blot
- WT:
-
wild type
References
Abrieu A, Magnaghi-Jaulin L, Kahana JA, Peter M, Castro A, Vigneron S et al. (2001). Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint. Cell 106: 83–93.
Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D . (1998). Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 58: 2170–2175.
Bharadwaj R, Yu H . (2004). The spindle checkpoint, aneuploidy, and cancer. Oncogene 23: 2016–2027.
Bhatt KV, Spofford LS, Aram G, McMullen M, Pumiglia K, Aplin AE . (2005). Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling. Oncogene 24: 3459–3471.
Borysov SI, Cheng AWM, Guadagno TM. (2006). B-Raf is critical for MAPK activation during mitosis and is regulated in an M phase-dependent manner in Xenopus egg extracts. J Biol Chem 281: 22586–22596.
Calipel A, Lefevre G, Pouponnot C, Mouriaux F, Eychene A, Mascarelli F . (2003). Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway. J Biol Chem 278: 42409–42418.
Chadee DN, Kyriakis JM . (2004). MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation. Nat Cell Biol 6: 770–776.
Cleveland DW, Mao Y, Sullivan KF . (2003). Centromeres and kinetochores: from epigenetics to mitotic checkpoint signaling. Cell 112: 407–421.
Conner SR, Scott G, Aplin AE . (2003). Adhesion-dependent activation of the ERK1/2 cascade is by-passed in melanoma cells. J Biol Chem 278: 34548–34554.
Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H et al. (2005). Distinct sets of genetic alterations in melanoma. N Engl J Med 353: 2135–2147.
Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. (2002). Mutations of the BRAF gene in human cancer. Nature 417: 949–954.
Eves EM, Shapiro P, Naik K, Klein UR, Trakul N, Rosner MR . (2006). Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell 23: 561–574.
Fisk HA, Winey M . (2001). The mouse Mps1p-like kinase regulates centrosome duplication. Cell 106: 95–104.
Fukushima T, Suzuki S, Mashiko M, Ohtake T, Endo Y, Takebayashi Y et al. (2003). BRAF mutations in papillary carcinomas of the thyroid. Oncogene 22: 6455–6457.
Hardwick KG, Weiss E, Luca FC, Winey M, Murray AW . (1996). Activation of the budding yeast spindle assembly checkpoint without mitotic spindle disruption. Science 273: 953–956.
Hingorani SR, Jacobetz MA, Robertson GP, Herlyn M, Tuveson DA . (2003). Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Res 63: 5198–5202.
Hoeflich KP, Gray DC, Eby MT, Tien JY, Wong L, Bower J et al. (2006). Oncogenic BRAF is required for tumor growth and maintenance in melanoma models. Cancer Res 66: 999–1006.
Horne MM, Guadagno TM . (2003). A requirement for MAP kinase in the assembly and maintenance of the mitotic spindle. J Cell Biol 161: 1021–1028.
Jallepalli PV, Lengauer C . (2001). Chromosome segregation and cancer: cutting through the mystery. Nat Rev Cancer 1: 109–117.
Jaspersen SL, Huneycutt BJ, Giddings Jr TH, Resing KA, Ahn NG, Winey M . (2004). Cdc28/Cdk1 regulates spindle pole body duplication through phosphorylation of Spc42 and Mps1. Dev Cell 7: 263–274.
Karasarides M, Chiloeches A, Hayward R, Niculescu-Duvaz D, Scanlon I, Friedlos F et al. (2004). B-RAF is a therapeutic target in melanoma. Oncogene 23: 6292–6298.
Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA . (2003). High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63: 1454–1457.
Knauf JA, Ouyang B, Knudsen ES, Fukasawa Kenji Babcock G, Fagin JA . (2006). Oncogenic Ras induces accelerated transition through G2/M and promotes defects in the G2 DNA damage and mitotic spindle checkpoints. J Biol Chem 281: 3800–3809.
Kops GJ, Weaver BA, Cleveland DW . (2005). On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5: 773–785.
Kumar R, Angelini S, Czene K, Sauroja I, Hahka-Kemppinen M, Pyrhonen S et al. (2003). BRAF mutations in metastatic melanoma: a possible association with clinical outcome. Clin Cancer Res 9: 3362–3368.
Liu ST, Chan GK, Hittle JC, Fujii G, Lees E, Yen TJ . (2003). Human MPS1 kinase is required for mitotic arrest induced by the loss of CENP-E from kinetochores. Mol Biol Cell 14: 1638–1651.
Liu X, Yan S, Zhou T, Terada Y, Erikson RL . (2004). The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23: 763–776.
Nasmyth K . (2002). Segregating sister genomes: the molecular biology of chromosome separation. Science 297: 559–565.
Palframan WJ, Meehl JB, Jaspersen SL, Winey M, Murray AW . (2006). Anaphase inactivation of the spindle checkpoint. Science 313: 680–684.
Park S, Yeung ML, Beach S, Shields JM, Yeung KC . (2005). RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene 24: 3535–3540.
Peeper DS, Shvarts A, Brummelkamp T, Douma S, Koh EY, Daley GQ et al. (2002). A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence. Nat Cell Biol 4: 148–153.
Peters JM . (2002). The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol Cell 9: 931–943.
Satyamoorthy K, Li G, Gerrero MR, Brose MS, Volpe P, Weber BL et al. (2003). Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res 63: 756–759.
Stahl JM, Sharma A, Cheung M, Zimmerman M, Cheng JQ, Bosenberg MW et al. (2004). Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res 64: 7002–7010.
Stucke VM, Sillje HH, Arnaud L, Nigg EA . (2002). Human Mps1 kinase is required for the spindle assembly checkpoint but not for centrosome duplication. EMBO J 21: 1723–1732.
Takenaka K, Gotoh Y, Nishida E . (1997). MAP kinase is required for the spindle assembly checkpoint but is dispensable for the normal M phase entry and exit in Xenopus egg cell cycle extracts. J Cell Biol 136: 1091–1097.
Wang XM, Zhai Y, Ferrell Jr JE . (1997). A role for mitogen-activated protein kinase in the spindle assembly checkpoint in XTC cells. J Cell Biol 137: 433–443.
Wellbrock C, Ogilvie L, Hedley D, Karasarides M, Martin J, Niculescu-Duvaz D et al. (2004). V599EB-RAF is an oncogene in melanocytes. Cancer Res 64: 2338–2342.
Wright JH, Munar E, Jameson DR, Andreassen PR, Margolis RL, Seger R et al. (1999). Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc Natl Acad Sci USA 96: 11335–11340.
Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C et al. (2002). Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res 62: 6451–6455.
Zhao Y, Chen RH . (2006). Mps1 phosphorylation by MAP kinase is required for kinetochore localization of spindle-checkpoint proteins. Curr Biol 16: 1764–1769.
Acknowledgements
We thank John Kyriakis, Daniel Peeper and Jiandong Chen for providing valuable reagents and Mark Winey for providing a protocol for immunostaining kinetochore-associated proteins. We also thank members of the Guadagno laboratory for their support and helpful suggestions. We acknowledge the support of the Analytical Microscopy (Joseph Johnson and Mark Lloyd), Molecular Biology and Flow Cytometry core facilities at the H. Lee Moffitt Cancer Center. This work was supported in part by the National Institutes of Health (grant GM62542) and a DOD-sponsored National Functional Genomics and Proteomics programmatic grant at Moffitt (to TMG). TM Guadagno was supported as a V Scholar by the Jimmy V Foundation.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Cui, Y., Guadagno, T. B-RafV600E signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells. Oncogene 27, 3122–3133 (2008). https://doi.org/10.1038/sj.onc.1210972
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210972
Keywords
This article is cited by
-
Oncogenic BRAF induces whole-genome doubling through suppression of cytokinesis
Nature Communications (2022)
-
Phosphorylation of Mps1 by BRAFV600E prevents Mps1 degradation and contributes to chromosome instability in melanoma
Oncogene (2013)
-
The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models
British Journal of Cancer (2012)
-
A MEK-independent role for CRAF in mitosis and tumor progression
Nature Medicine (2011)
-
Mps1
AfCS-Nature Molecule Pages (2010)